2013
DOI: 10.1590/s1676-24442013000600003
|View full text |Cite
|
Sign up to set email alerts
|

Oxacillinase (OXA)-producing Acinetobacter baumannii in Brazil: clinical and environmental impact and therapeutic options

Abstract: Following a worldwide trend, infections caused by MDR OXA-type (Ambler class D) carbapenemase-producing Acinetobacter baumannii are currently regarded as a clinical and epidemiological emergency in Brazil. OXA-producing A. baumannii strains have been identified in the states of Alagoas,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
9
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 134 publications
(105 reference statements)
2
9
0
2
Order By: Relevance
“…A study in Romania reported highly resistant A. baumannii isolates with 75% resistance for ceftriaxone, ceftazidime, gentamicin and kanamycin antibiotics each [ 27 ] and a study conducted in Ethiopia also revealed 100% and 88% resistant Ciprofloxacin and Gentamicin A.baumannii from environmental isolates respectively [ 28 ]. Ciprofloxacin resistant, 86.5% A.baumannii isolates were also detected in clinical and environmental isolates in Brazil [ 29 ] and 92.2% TMP-SXT resistant isolates were also identified in hospital waste effluent in Denmark [ 30 ]. Similarly, high antibiotic resistance percentage were also found in Bangladesh from isolates collected from endotracheal tube with 100% resistance for ceftriaxone and gentamicin, and 66.7% for amikacin and impenem 66.7% [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…A study in Romania reported highly resistant A. baumannii isolates with 75% resistance for ceftriaxone, ceftazidime, gentamicin and kanamycin antibiotics each [ 27 ] and a study conducted in Ethiopia also revealed 100% and 88% resistant Ciprofloxacin and Gentamicin A.baumannii from environmental isolates respectively [ 28 ]. Ciprofloxacin resistant, 86.5% A.baumannii isolates were also detected in clinical and environmental isolates in Brazil [ 29 ] and 92.2% TMP-SXT resistant isolates were also identified in hospital waste effluent in Denmark [ 30 ]. Similarly, high antibiotic resistance percentage were also found in Bangladesh from isolates collected from endotracheal tube with 100% resistance for ceftriaxone and gentamicin, and 66.7% for amikacin and impenem 66.7% [ 31 ].…”
Section: Discussionmentioning
confidence: 99%
“…Os mecanismos de resistência do A. baumannii podem ter origem intrínseca ou adquirida e são mediados por diversos fatores, como perda da permeabilidade da membrana e, mais expressivamente, produção de betalactamases, enzimas que degradam antibióticos betalactâmicos, sendo a principal causa de resistência bacteriana 9 . Carbapenemases representam o grupo mais versátil de beta-lactamases, devido ao seu amplo espectro de ação.…”
Section: Mecanismos De Resistênciaunclassified
“…As regiões sul e sudeste do país apresentam maior incidência de cepas multirresistentes deste microrganismo 9 23 .…”
Section: Aspectos Epidemiológicosunclassified
“…OXA-143 is still little studied and restricted to Brazil. It was identified in a clinical isolate of multidrug-resistant A. baumanni [26][27][28][29]. β-lactamase OXA-143 hydrolyzes penicillins and carbapenems but does not significantly hydrolyze expanded-spectrum cephalosporins, as observed with other carbapenem-hydrolyzing class D-β-lactamase [26].…”
Section: Introductionmentioning
confidence: 98%